12.1 Adequate pain relief as reported by the woman |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
12.1.1 Ketorolac 5 mg versus Ketorolac 10 mg |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
12.2 Need for additional pain relief |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
12.2.1 Ketorolac 5 mg versus Ketorolac 10 mg |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
12.3 Maternal adverse events |
1 |
60 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.86 [0.33, 2.25] |
12.3.1 Ketorolac 5 mg vs Ketorolac 10 mg |
1 |
60 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.86 [0.33, 2.25] |